Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDP-122 Lotion vs Ultravate Cream in Plaque Psoriasis
NCT02785185Phase 2Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Jun 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Halobetasol propionate 0.05% lotion in plaque psoriasis, sponsored by Valeant Pharmaceuticals. Started Jun 2016; status: completed.
02
Drugs
Halobetasol propionate 0.05% lotion
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02785185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02785185.